The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma.
Renouf DJ, Loree JM, Knox JJ, Topham JT, Kavan P, Jonker D, Welch S, Couture F, Lemay F, Tehfe M, Harb M, Aucoin N, Ko YJ, Tang PA, Ramjeesingh R, Meyers BM, Kim CA, Du P, Jia S, Schaeffer DF, Gill S, Tu D, O'Callaghan CJ.
Renouf DJ, et al. Among authors: meyers bm.
Nat Commun. 2022 Aug 26;13(1):5020. doi: 10.1038/s41467-022-32591-8.
Nat Commun. 2022.
PMID: 36028483
Free PMC article.
Clinical Trial.